Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1999-11-15
2000-09-19
Vollano, Jean F
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514107, 562 20, 562 21, 556405, A61K 31095, A61K 3112, C07F 938
Patent
active
061212539
ABSTRACT:
This invention relates to prostaglandin-bisphosphonate conjugates. These conjugates are effective for treating or preventing bone diseases such as osteoporosis. These conjugates simultaneously deliver a prostaglandin agent for increasing bone formation and a bisphosphonate agent for inhibiting bone resorption.
REFERENCES:
patent: 3927197 (1975-12-01), Monkhouse
patent: 3975404 (1976-08-01), Lincoln, Jr. et al.
patent: 4018892 (1977-04-01), Walsh
patent: 4097601 (1978-06-01), Schaaf
patent: 4171331 (1979-10-01), Biddlecom et al.
patent: 4621100 (1986-11-01), Lund et al.
patent: 4761406 (1988-08-01), Flora et al.
patent: 4921697 (1990-05-01), Peterlik et al.
patent: 5071655 (1991-12-01), Baylink
patent: 5071840 (1991-12-01), Ebetino et al.
patent: 5118667 (1992-06-01), Adams et al.
patent: 5409911 (1995-04-01), Tyler et al.
Klenner et al, J. Cancer Res. Clin. Oncol., vol. 116 (1990), pp. 341-350, "Anticancer-agent-linked phosphonates with antiosteolytic and antineoplastic properties: . . . ".
Harvey et al., Prostaglandins in Bone Resorption, (1988) Chapt. 3--"IV. Effects on Bone Formation", pp. 36-41.
Jee et al., Bone & Mineral, vol. 15 (1991), pp. 33-55, "Long-term anabolic effects of prostaglandin-E2 on tibial diaphyseal bone in male rats".
Raisz et al., Ann. Rev. Physiol., vol. 43 (1981), pp. 225-238, "Hormonal control of skeletal growth".
Rodan, J. Cellular Biochem. Suppl. 0 (15, Part F), pp. 160, Abstract Q 018 (1991), "Cellular approaches to therapy for the prevention and treatment of osteoporosis".
Frost, Clinical Orthopedics & Related Research, vol. 143 (1979), pp. 227-244, "Basic Science and Pathology: Treatment of osteoporoses by manipulation of coherent bone cell populations".
Ueno et al., Bone, vol. 6 (1985), p. 79-86, "The effects of prostaglandin E2 in rapidly growing rats: depressed longitudinal and radial growth and increased metaphyseal hard tissue mass".
Jee et al., Calcif. Tissue Int., vol. 37 (1985), pp. 148-157, "The effects of prostaglandin E2 in growing rats: Increased metaphyseal hard tissue and cortico-endosteal bone formation".
Gil Laurent
Han Yongxin
Ruel Rejean
Young Robert N.
Merck Frosst Canada & Co.
Sabatelli Anthony D.
Vollano Jean F
Winokur Melvin
LandOfFree
Prostaglandin conjugates for treating or preventing bone disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prostaglandin conjugates for treating or preventing bone disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostaglandin conjugates for treating or preventing bone disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1073345